©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Jun 15, 2017; 8(6): 278-285
Published online Jun 15, 2017. doi: 10.4239/wjd.v8.i6.278
Published online Jun 15, 2017. doi: 10.4239/wjd.v8.i6.278
Treatment of type 2 diabetes mellitus in the elderly
Funda Datli Yakaryılmaz, Zeynel Abidin Öztürk, Division of Geriatric Medicine, Department of Internal Medicine, Faculty of Medicine, Gaziantep University, 27100 Sahinbey, Gaziantep, Turkey
Author contributions: Both authors contributed to this paper.
Conflict-of-interest statement: None to declare.
Correspondence to: Zeynel Abidin Öztürk, MD, Division of Geriatric Medicine, Department of Internal Medicine, Faculty of Medicine, Gaziantep University, Osmangazi Avenue, University Street, 27100 Sahinbey, Gaziantep, Turkey. zabidinozturk@gantep.edu.tr
Telephone: +90-342-3416689 Fax: +90-342-3606060
Received: March 3, 2017
Peer-review started: March 7, 2017
First decision: April 18, 2017
Revised: May 11, 2017
Accepted: May 18, 2017
Article in press: May 19, 2017
Published online: June 15, 2017
Processing time: 103 Days and 9.1 Hours
Peer-review started: March 7, 2017
First decision: April 18, 2017
Revised: May 11, 2017
Accepted: May 18, 2017
Article in press: May 19, 2017
Published online: June 15, 2017
Processing time: 103 Days and 9.1 Hours
Core Tip
Core tip: Diabetes mellitus (DM) is one of the most common lifelong chronic diseases in the world and its ratio is increasing by aging population. Elderly patients with type 2 DM have an increased risk for coronary heart disease, stroke and vascular diseases. While determining the treatment target and treatment options in elderly individuals, the functional capacity of the individual, comorbid diseases and treatment compliance should be evaluated together.